Approval · Notice of Compliance 6809 · 2005

FOSAMAX: Notice of Compliance 6809

Issued May 16, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 6809
Date: May 16, 2005
Company: Merck Frosst Canada Ltd., Merck Frosst Canada Ltée
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Bone metabolism regulator

Products in this notice

Brand	DIN	Status today
FOSAMAX	02233055	Cancelled Post Market
FOSAMAX	02201011	Cancelled Post Market
FOSAMAX	02201038	Cancelled Post Market
FOSAMAX	02245329	Marketed
FOSAMAX	02248625	Cancelled Post Market

Medicinal ingredients

ALENDRONATE SODIUM 5 MG per TAB
ALENDRONATE SODIUM 10 MG per TAB
ALENDRONATE SODIUM 40 MG per TAB
ALENDRONATE SODIUM 70 MG per TAB
ALENDRONATE SODIUM 70 MG per 75ML